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Abstract Maintenance of articular cartilage allo-
grafts in culture media is a common method of tissue
storage; however, the technical parameters of graft
storage remain controversial. In this study, we exam-
ined the optimal temperature and culture medium
exchange rate for the storage of osteochondral
allografts in vitro. Cylindrical osteochondral grafts
(n = 120), harvested from the talar joint surface of ten
Boer goats, were randomly classified into four groups
and stored under the following conditions: Group A1
was maintained at 4 C in culture medium that was
refreshed every 2 days; Group A2 was maintained at
4 C in the same culture medium, without refreshing;
Group B1, was maintained at 37 C in culture medium
that was refreshed every 2 days; Group B2, was
maintained at 37 C in the same culture medium,
without refreshing. Chondrocyte viability in the grafts
was determined by ethidium bromide/fluorescein
diacetate staining on days 7, 21, and 35. Proteoglycan
content was measured by Safranin-O staining. Group
A1 exhibited the highest chondrocyte survival rates of
90.88 %, 88.31 % and 78.69 % on days 7, 21, and 35,
respectively. Safranin O staining revealed no signif-
icant differences between groups on days 21 and 35.
These results suggest that storage of osteochondral
grafts at 4 C with regular culture medium replace-
ment should be highly suitable for clinical application.
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Introduction
Clinical transplantations of osteochondral allografts to
treat articular cartilage defects have been carried out
for about 30 years (Gross et al. 1975). Transplantation
using fresh osteochondral grafts is a routine clinical
treatment approach resulting in excellent chondrocyte
viability and good clinical results (Farr et al. 2011).
However, the problem with using fresh transplantation
tissue is that the patient needs to wait at least 2 weeks
for disease screening to take place, to reduce the
potential risk of disease transmission. The researcher
has been conducted to establish novel methods to
maintain the viability of cartilage grafts for storage as
long as possible in vitro. However, short storage times
with reduced cell viability of osteochondral grafts
remained an issue in clinical transplantation (Cook
et al. 2014).
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Many researchers have investigated the influence of
various factors on the viability of articular cartilage
preserved in vitro, including tissue culture medium
components, storage temperature, medium replacement,
and othermicroenvironment factors. To date, the storage
time of osteochondral grafts in tissue culturemediumhas
reached 28 days (Bian et al. 2010). Regarding storage
temperature, dispute exists between whether to store at
body temperature (37 C) or in a thermostat refrigerator
(4 C). Several studies report that ex vivo storage of
articular cartilage is better at 37 C compared with 4 C
(Bastian et al. 2011; Bian et al. 2010; Pallante et al.
2009). However, the issue with graft storage at 37 C is
that microorganism growth can occur, which increases
the infection risk and contributes to high storage costs
(Stoker et al. 2012). Storage at 4 C in a tissue bank has
been the standard approach for many years, with the
advantages of low risk of microbial infection, low
storage cost, and an approach that is more widely
accepted (Bae et al. 2009; Bian et al. 2010; Linn et al.
2011; Malinin 2006; Onuma et al. 2012; Williams et al.
2004). With respect to culture medium replacement,
some researchers have shown that periodic medium
replacement is beneficial for tissue viability during
storage (Bian et al. 2010; Linn et al. 2011;Williams et al.
2004), whilst others do not agree with medium replace-
ment (Bae et al. 2009). Csonge and colleagues conclude
that medium replacement or not during storage does not
influence tissue viability, and that changing the medium
more frequently may in fact cause microenvironment
instability of cartilage explants (Csonge et al. 2002).
In view of these reports, we aimed to investigate both
storage temperature and medium replacement of osteo-
chondral grafts stored ex vivo in culture medium.
Following storage in culture medium at 4 and 37 C,
with and without medium changes, we compared
chondrocyte viability and proteoglycan (PG) content
of the cartilage matrix. We hypothesized that a temper-
ature of 4 C with medium replacement would be more
beneficial in maintaining osteochondral grafts in vitro.
Materials and methods
Osteochondral tissue processing and storage
conditions
Use of Boer goats and experimental designs were
approved by the Experimental Animal Committee of
Taishan Medical University. Ankle talus cartilage
specimens (n = 120) containing subchondral bone
were harvested from both lower extremities of ten
healthy 8-month-old Boer goats (male and female;
average weight, 80 kg). Six osteochondral graft sam-
ples were harvested from each ankle joint under
sterile. Each sample was 6.0 mm in diameter and
comprised full-thickness articular cartilage and
5.0 mm of subchondral bone. All samples were
obtained under aseptic conditions and were confirmed
to be healthy osteochondral tissues prior to surgery.
Graft samples were washed three times with sterile
phosphate buffered saline (PBS) to remove residual fat
and marrow tissues. Samples were then placed into
sterile containers filled with Eagle’s Minimum Essen-
tial Medium (EMEM, Gibco, MA, USA). Samples
were then divided randomly into four groups
(n = 30/group). Samples in each group were then
maintained in the different storage conditions high-
lighted in Table 1. Group A1 samples were stored at
4 C in a thermostat refrigerator (BCD-186KB, Haier,
Qingdao, China) with medium replacement every
2 days. Group A2 samples were stored at 4 C in a
thermostat refrigerator without culture medium
replacement. Group B1 samples were stored at
37 C in a thermostatic chamber (MCO-15AC,
SANYO, Osaka, Japan) with 5 % CO2 and medium
replacement every 2 days. Group B2 samples were
stored at 37 C in a thermostatic chamber with 5 %
CO2 and without medium replacement.
Before testing, the cartilage samples in Groups A1
and Groups A2 were warmed by direct immersion in a
37 C water bath for 30 min. Chondrocyte viability
and matrix PG content of the cartilage samples in each
group were assessed on days 7, 21 and 35.
Determination of cartilage cell viability
To determine cell viability of the cartilage samples,
samples were cut into 1.0 mm3 pieces and digested in
0.25 % trypsase ? EDTA (ethylene diamine tetra-
acetic acid)-2Na (Solarbio, China) and 0.2 % colla-
genase II (Sigma, NY, USA) in a 37 C water bath for
40 min and 4 h, respectively. Using this approach,
individual chondrocytes were obtained from the
cartilage matrix. Cell survival was investigated by
fluorescence staining with 50 mg/L fluorescein diac-
etate (FDA) and 10 mg/L ethidium bromide (EB,
Sigma) (Cohen et al. 2000; Muldrew et al. 1994). FDA
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is a lipid that does not cause luminescence by itself,
after crossing the cytomembrane, is decomposed by
non-specific esterase to become a fluorescein, which is
observed as green fluorescence at a wavelength of
480 nm. EB is a highly sensitive fluorescein that
cannot cross a living cell cytomembrane. However,
EB can cross the cytomembrane of dead cells,
whereby it combines with the DNA, and is observed
as red fluorescence at a wavelength of 480 nm. Cells
with orange luminescence (a combination of green and
red) were also considered dead. Chondrocytes stained
with EB-FDA were incubated at 37 C for 30 min.
Cell smears were then observed under a fluorescence
microscope (BX51, Olympus, Tokyo, Japan) and cell
viability was calculated using image analysis software
(Image-Pro Plus 6.0 Media, Cybernetics, MD, USA).
Calculations were conducted by randomly observing
10 non-overlapping fields of view and counting the
total cell number (green, red and orange cells) and
determining the proportion of green cells (Muldrew
et al. 1994; Stoker et al. 2012).
Determination of cartilage matrix PG content
All cartilage specimens were processed as follows:
samples were fixed in 4 % paraformaldehyde solution
(Sigma) for 36 h and then decalcified by immersion in
40 % EDTA-2Na solution (Solarbio) for 2 weeks.
The full-thickness tissues were then rip-cut sectioned
into 8-mm slices and stained with Safranin-O stain
(Sigma) to determine PG content. Stained samples
were observed under a microscope (IX-71, OLYM-
PUS, Tokyo, Japan) and photographed. For each
specimen, 10 random non-overlapping fields of view
were observed. Image-Pro Plus 6.0 software (Media
cybernetics, MD, USA) was used to determine the
integrated optical density (IOD) of the Safranin-O
stain intensity, to quantitatively determine PG
content.
Statistical methods
Statistical analysis was performed using SPSS 13.0
software. Experimental data are represented as
mean ± standard deviation (SD). Cell viability per-
centages and Safranin-O staining IOD values, repre-
sentative of PG content, were statistically analyzed
using analysis of variance (ANOVA) within each




EB/FDA fluorescent staining of chondrocytes
Figure 1 shows live green and dead red fluorescent
chondrocytes in each group. Regardless of tempera-
ture and medium change regimen, there were very few
dead cells observed at day 7 in all groups, with no
significant differences recorded. At day 21, the
proportion of dead cells increased in comparison with
day 7 for all groups; by day 35, the proportion of dead
cells had increased for all groups. At day 35, cell
viability was highest in Group A1, which was stored at
4 C with medium changes. Interestingly, cell viabil-
ity was higher in Groups A1 and A2 (storage at 4 C),
compared with Groups B1 and B2 (storage at 37 C),
respectively, and in Groups A1 and B1 (with medium
changes), compared with Groups A2 and B2 (without
medium change), respectively. These data indicate
that storage at 4 C with medium changes was more
beneficial for cell viability of the osteochondral grafts.
Chondrocyte survival rate
As shown in Fig. 2, culture medium replacement
influenced chondrocyte viability at all time points. The
Table 1 Storage condition Storage condition Temperature (C) Medium replacement
(every 2 days)
Duration (days)
A1 4 Yes 7, 21, and 35
A2 4 No 7, 21, and 35
B1 37 Yes 7, 21, and 35
B2 37 No 7, 21, and 35
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chondrocyte survival rate was higher in the medium
replacement groups compared with those without
medium replacement. In addition, compared with day
7, temperature and the interaction between tempera-
ture and culture medium replacement affected cell
viability on days 21 and 35, with a greater number of
viable cells in 4 C compared with 37 C storage.
When considering the interaction of the two factors,
chondrocyte viability was significantly higher at 4 C
when the medium was replaced (Group A1). In
addition, cell viability clearly decreased in all four
groups over time, indicating that time is an important
factor affecting cell viability.
Proteoglycan of articular cartilage
Safranin-O staining of PG
As shown in Fig. 3, all cartilage explants at day 7
contained large amounts of positively stained PG,
observed from the explant surfaces to the inner layers.
After 21 days, PG content in the cartilage matrix was
significant decreased in all groups, with different
layers showing different rates of PG reduction. The
surface layer displayed the most obvious PG loss, with
less PG loss in the middle layer and the deep layer
closest to the subchondral bone containing the most
PG. At day 35, PG loss was more significant in all
groups.
Fig. 1 EB-FDA fluorescence staining of chondrocytes at days
7, 21 and 35 in different storage conditions. Chondrocytes
emitting green (alive) and red (dead) fluorescence are shown at
each time point. Blue dots represent impurities. At day 7, dead
cell numbers were low in all groups. Viable chondrocyte
numbers were significantly higher in Group A1 compared with
the other three groups. On day 21, there were more dead cells
than on day 7 for all groups. On day 35, dead cell numbers
continued to increase in all groups, with the highest numbers in
Group B1 and Group B2. (Color figure online)
Fig. 2 Chondrocyte survival rate (%) variation at days 7, 21
and 35 in different storage conditions (*P\ 0.05; ***P\ 0.01)
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Quantitative determination of PG
As shown in Fig. 4, the IOD value of Safranin-O
staining of cartilage matrix was significantly higher in
Group A than in the other three groups on day 7 of
preservation. On days 21 and 35, Safranin-O IOD
values were obvious decreased in all groups; however,
there were no significant differences between groups.
Discussion
Since the beginning of the twenty-first century,
researchers have deduced a set of crude tissue culture
preservation methods for articular cartilage in vitro,
which are used prior to the clinical transplantation of
articular cartilage into defects. However, the biggest
issue is successfully maintaining tissue viability over a
short time, usually 2–4 weeks. Williams reports that
the physiological function of cartilage is maintained to
a higher level 7 days after cartilage harvest, after
which all physiological functions decline to day 14,
with significant decrease in function by day 28
(Williams et al. 2003). Our study identified a similar
phenomenon to this, in that chondrocyte viability and
the cartilage matrix PG component decreased signif-
icantly after 3 weeks. To improve the tissue culture
environment therefore, optimizing an extended stor-
age time in vitro may permit enough time for
preoperative graft preparation, graft transportation
and patient hospital care prior to clinical transplanta-
tion. Although previous studies have focused on the
influence of different storage temperatures on
Fig. 3 Safranin-O staining of full-thickness cartilage matrix on
days 7, 21, and 35 in different storage conditions. On day 7th, an
abundance of Safranin-O stained PG was observed in the matrix
from the superficial layer to the deep layer in all groups. On days
21 and 35, PG content decreased in all groups, with no
significant differences between groups. On day 35 PG content
decreased further more
Fig. 4 IOD values of Safranin-O staining in cartilage on days 7,
21 and 35 in different storage conditions (*P\ 0.05)
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preservation, they have not focused on the interaction
of temperature and medium changes.
Fluorescent staining showed that grafts preserved at
4 C with medium replacement every 2 days (Group
A1) benefited with respect to chondrocyte viability
compared with the other groups. We believe there are
clear reasons for this finding. Firstly, storage at 4 C
would inhibit activity of various enzymes in the
chondrocytes, and the metabolic rate would be lower
while compared with storage at 37 C. Furthermore,
the nutrition demand of cells at 4 C is reduced while
compared with storage at 37 C. After re-warming the
cartilage explants, enzyme activity recovers and the
chondrocytes are able to return to a higher metabolic
status. Secondly, the timely replacement of medium
would supply new nutrients to the cartilage, including
amino acids and electrolytes, thus maintaining high
chondrocyte viability. Conversely, when stored at the
37 C, although the chondrocytes are not injured, their
enzyme activity remains high; their cell metabolism
and nutrient requirements therefore also remain high,
leading to the need for more medium changes.
The Safranin O staining IOD value indicates the PG
production level within the articular cartilage matrix.
We found that temperature and the interaction between
temperature and culture medium replacement did not
affect the IOD value of the cartilage matrix at days 21
and 35. We believe this was because the Safranin-O
staining IOD value was not sensitive enough. Further-
more, on days 21 and 35, storage at 4 C inhibited cell
metabolism and cell synthesis, resulting in less PG
degradation. At 37 C, however, PG synthesis reduced
because of insufficient nutrients and increased meta-
bolic rate, resulting in higher PG degradation.
In our study, with the same frequency of medium
replacement, storage of explants at 4 C was clearly
better than at 37 C.Researchers highlight three reasons
for differences in results (Garrity et al. 2012; Pallante
et al. 2009). First, experimental animals of different ages
and sites of cartilage harvest can influence the results.
Pallante used bone cartilage from different locations of
the humeral head in 3–4-year-old male goats. Garrity
used tissues from adult canine knees, more specifically
the femoral half condyle and tibia platformhalf condyle.
Our experiment used 8-month-old local goat ankle
cartilage. Secondly, with respect to differences in the
culture medium components, Pallante used MEME
containing 10 % FBS, whilst Garrity used Dulbecco’s
modified Eagle’s medium (DMEM), whilst we used
EMEM in our study. Finally, there were differences in
cell viability testing methods. Pallante assessed chon-
drocyte viability in cartilage slices using calcein AM/
methidiumhomodimer-1 by immunofluorescence stain-
ing and Garrity assessed cartilage slices using CMFDA/
EthD-1 (5-chloromethylfluorescein diacetate/ethidi-
umhomodimer-1) staining. In our study, we used EB-
FDA staining of the cartilage cells following digestion,
which may account for differences between studies.
The EB/FDA dual fluorescent staining method used
in our study is simple, intuitive and accurate, and has
been used in a variety of animal and plant cell activity
andmicrobiology tests. Jomha and Cohen report that this
method is reliable (Cohen et al. 2000; Jomha et al. 2002).
We verified good conformability in the viability testing
in both EB/FDA immunofluorescence staining of the
digest the cartilage cells and ED/FDA immunofluores-
cence staining of the cartilage cells in tissue slices, with
both methods complimenting each other.
Some limitations exist in this study. First, we used
cartilage samples taken from goats rather than humans.
Second, our study did not take into account pH values
experienced in storage. The tissue samples stored at 4 C
were in closed vessels, while at 37 C the vessels were
open, meaning CO2 concentrations also differed, which
may affect pH value variations. In a recent study, bovine
osteochondral graftswere storedat4 Cand the liquidpH
value increased during subsequent storage in ambient air,
reducing the survival rate of the cartilage cells. Interest-
ingly, storage in CO2 did not normalize the pH value and
improve the overall survival rate (Dontchos et al. 2008).
CO2 may therefore be the affecting factor for this result.
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